Xvivo Perfusion AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Xvivo Perfusion AB receives market approval from FDA for Steen Solution and XPS
XvivoPerfusion AB:Receives market approval from the FDA for steen Solution(TM) and Xps(TM).
Latest Developments for Xvivo Perfusion AB
- XVIVO Perfusion AB receives CE mark for XPS
- XVIVO Perfusion AB announces FDA Advisory Panel's decision that XPS with STEEN Solution meets requirements for HDE approval
- XVIVO Perfusion AB Appoints KPMG as New Auditing Company
- XVIVO Perfusion AB Receives Marketing Approval for Steen Solution in Canada
- Share this
- Digg this